Swiss National Bank Kymera Therapeutics, Inc. Transaction History

Swiss National Bank

$146 Billion
Q4 2024

A detailed history of Swiss National Bank transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 76,200 shares of KYMR stock, worth $2.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,200

Previous 65,900 15.63%

Holding current value

$2.8 Million

Previous $3.12 Million 1.73%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$39.06 - $51.84 $402,318 - $533,952	10,300 Added 15.63%	76,200 $3.07 Million
Q3 2024 Nov 07, 2024	SELL	$30.16 - $52.4 $729,872 - $1.27 Million	-24,200 Reduced 26.86%	65,900 $3.12 Million
Q2 2024 Aug 08, 2024	BUY	$29.85 - $39.42 $310,440 - $409,968	10,400 Added 13.05%	90,100 $2.69 Million
Q1 2024 May 07, 2024	BUY	$22.9 - $43.57 $199,230 - $379,059	8,700 Added 12.25%	79,700 $3.2 Million
Q4 2023 Feb 06, 2024	SELL	$10.97 - $26.84 $88,857 - $217,404	-8,100 Reduced 10.24%	71,000 $1.81 Million
Q3 2023 Nov 08, 2023	BUY	$13.9 - $23.88 $180,700 - $310,440	13,000 Added 19.67%	79,100 $1.1 Million
Q2 2023 Aug 09, 2023	SELL	$22.4 - $34.92 $244,159 - $380,628	-10,900 Reduced 14.16%	66,100 $1.52 Million
Q1 2023 May 10, 2023	SELL	$24.84 - $38.75 $109,296 - $170,500	-4,400 Reduced 5.41%	77,000 $2.28 Million
Q4 2022 Feb 08, 2023	BUY	$19.57 - $30.92 $33,269 - $52,564	1,700 Added 2.13%	81,400 $2.03 Million
Q3 2022 Nov 09, 2022	BUY	$20.91 - $34.27 $20,910 - $34,270	1,000 Added 1.27%	79,700 $1.74 Million
Q2 2022 Aug 09, 2022	BUY	$14.13 - $42.55 $166,734 - $502,089	11,800 Added 17.64%	78,700 $1.55 Million
Q1 2022 May 09, 2022	BUY	$35.3 - $64.68 $180,030 - $329,868	5,100 Added 8.25%	66,900 $2.83 Million
Q4 2021 Feb 08, 2022	BUY	$49.91 - $65.56 $64,882 - $85,228	1,300 Added 2.15%	61,800 $3.92 Million
Q3 2021 Nov 08, 2021	BUY	$47.8 - $66.66 $1.71 Million - $2.39 Million	35,800 Added 144.94%	60,500 $3.55 Million
Q2 2021 Aug 06, 2021	SELL	$31.08 - $51.95 $15,540 - $25,975	-500 Reduced 1.98%	24,700 $1.2 Million
Q4 2020 Feb 05, 2021	BUY	$28.07 - $87.83 $707,364 - $2.21 Million	25,200 New	25,200 $1.56 Million

Others Institutions Holding KYMR

# of Institutions

186

Shares Held

65.5M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.01B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Kymera Therapeutics, Inc. Transaction History